Your browser is no longer supported. Please, upgrade your browser.
VCYT Veracyte, Inc. daily Stock Chart
VCYT [NASD]
Veracyte, Inc.
Index- P/E- EPS (ttm)-0.62 Insider Own1.00% Shs Outstand57.48M Perf Week-12.80%
Market Cap2.20B Forward P/E- EPS next Y-0.42 Insider Trans-45.65% Shs Float50.24M Perf Month24.09%
Income-30.90M PEG- EPS next Q-0.21 Inst Own- Short Float6.93% Perf Quarter23.48%
Sales112.50M P/S19.59 EPS this Y56.00% Inst Trans0.17% Short Ratio6.16 Perf Half Y47.82%
Book/sh4.50 P/B8.30 EPS next Y49.40% ROA-11.70% Target Price37.40 Perf Year79.69%
Cash/sh2.50 P/C14.94 EPS next 5Y- ROE-13.30% 52W Range13.90 - 44.64 Perf YTD33.74%
Dividend- P/FCF- EPS past 5Y27.40% ROI-6.30% 52W High-16.35% Beta0.43
Dividend %- Quick Ratio12.60 Sales past 5Y25.80% Gross Margin65.20% 52W Low168.63% ATR2.07
Employees354 Current Ratio13.20 Sales Q/Q-31.20% Oper. Margin-29.50% RSI (14)49.49 Volatility6.23% 5.31%
OptionableYes Debt/Eq0.00 EPS Q/Q-301.30% Profit Margin-27.50% Rel Volume0.83 Prev Close39.05
ShortableYes LT Debt/Eq0.00 EarningsNov 02 AMC Payout- Avg Volume564.38K Price37.34
Recom1.80 SMA20-0.64% SMA507.83% SMA20032.07% Volume470,350 Change-4.38%
Sep-09-20Initiated Morgan Stanley Underweight $35
Jul-31-19Initiated Lake Street Buy $35
Jul-02-19Initiated Needham Buy $33
Nov-29-18Downgrade Janney Buy → Neutral
Oct-31-18Upgrade Janney Neutral → Buy
Nov-07-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Janney Buy → Neutral
Aug-31-17Resumed BTIG Research Buy $13
Nov-14-16Resumed Leerink Partners Outperform $12
Dec-18-15Initiated Cantor Fitzgerald Buy $13
Jun-11-15Reiterated Leerink Partners Outperform $11 → $13
Nov-26-13Initiated William Blair Outperform
Oct-22-20 04:05PM  
Oct-19-20 08:15AM  
Oct-14-20 04:05PM  
Oct-07-20 08:15AM  
Sep-24-20 08:15AM  
Sep-15-20 04:30PM  
Sep-14-20 01:45PM  
Sep-11-20 08:15AM  
Sep-09-20 09:44AM  
Sep-04-20 08:15AM  
Aug-24-20 08:15AM  
Aug-07-20 04:15PM  
Aug-05-20 04:15PM  
03:26PM  
08:15AM  
Aug-04-20 07:27PM  
Aug-03-20 04:10PM  
Aug-02-20 10:53AM  
Jul-30-20 07:10PM  
04:05PM  
08:15AM  
Jul-29-20 08:15AM  
Jul-27-20 08:15AM  
Jul-23-20 12:33PM  
Jul-16-20 07:21PM  
08:15AM  
Jul-05-20 05:06PM  
Jun-29-20 02:06PM  
Jun-11-20 08:23AM  
07:30AM  
Jun-09-20 08:15AM  
Jun-04-20 05:00PM  
May-27-20 08:15AM  
May-22-20 06:22PM  
07:29AM  
May-21-20 08:15AM  
May-18-20 03:42PM  
08:25AM  
May-14-20 08:15AM  
May-07-20 04:05PM  
09:31AM  
May-06-20 07:05PM  
04:05PM  
03:00PM  
May-01-20 08:15AM  
Apr-29-20 12:34PM  
Apr-23-20 01:07PM  
Apr-17-20 07:35AM  
Apr-16-20 04:30PM  
Apr-13-20 10:54AM  
Apr-08-20 07:00PM  
Apr-07-20 08:15AM  
Apr-02-20 08:38AM  
Apr-01-20 08:15AM  
Mar-10-20 03:18AM  
Mar-02-20 11:00AM  
Feb-26-20 10:28AM  
Feb-25-20 06:05PM  
04:05PM  
Feb-13-20 08:15AM  
Feb-06-20 01:30PM  
Jan-20-20 02:44PM  
Jan-08-20 08:15AM  
Dec-13-19 09:06AM  
Dec-04-19 11:56AM  
07:06AM  
Dec-03-19 06:05PM  
05:09PM  
05:00PM  
Nov-02-19 09:30AM  
Oct-31-19 04:30AM  
Oct-30-19 08:15AM  
Oct-27-19 02:00PM  
Oct-24-19 06:42AM  
Oct-22-19 04:15PM  
07:00AM  
Oct-21-19 04:15PM  
09:57AM  
Oct-09-19 03:14PM  
Oct-08-19 04:30PM  
Oct-07-19 08:00AM  
Sep-11-19 11:04AM  
Sep-10-19 08:22AM  
Aug-28-19 04:15PM  
Aug-13-19 12:45PM  
Aug-02-19 06:51PM  
Jul-31-19 01:24AM  
Jul-30-19 07:45PM  
04:15PM  
Jul-23-19 10:32AM  
Jul-17-19 07:42AM  
Jul-01-19 08:00AM  
Jun-27-19 04:15PM  
Jun-26-19 04:15PM  
Jun-24-19 08:30AM  
Jun-21-19 09:35AM  
Jun-20-19 03:29PM  
Jun-17-19 08:30AM  
Jun-14-19 02:59PM  
09:49AM  
Veracyte, Inc. operates as a genomic diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to identify patients with benign thyroid nodules among those with indeterminate cytopathology results in order to rule out unnecessary thyroid surgery; Percepta Genomic Sequencing Classifier for lung cancer; Envisia Genomic Classifier that help physicians to differentiate idiopathic pulmonary fibrosis from other interstitial lung diseases without the need for surgery; and Prosigna Breast Cancer Prognostic Gene Signature Assay test for assessing risk of distant recurrence. It sells its products through product specialists, account managers, and medical science specialists. Veracyte, Inc. has a strategic collaboration with Johnson & Johnson Innovation and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages; a research collaboration with Loxo Oncology for the development of therapies for patients with genetically defined cancers; and a collaboration with Johnson & Johnson Services, Inc. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ho MarkPrincipal Accounting OfficerOct 20Option Exercise6.457,50048,37532,961Oct 21 06:22 PM
Cohen Fred EDirectorOct 19Option Exercise7.6010,00076,00010,000Oct 20 05:40 PM
Anderson Bonnie HChairman and CEOOct 08Option Exercise8.8650,000443,000270,231Oct 09 05:07 PM
Anderson Bonnie HChairman and CEOOct 08Sale38.0050,0001,900,000220,231Oct 09 05:07 PM
Kennedy Giulia CChief Scientific & Med OfficerOct 06Option Exercise20.212,50050,52581,899Oct 07 05:06 PM
Kennedy Giulia CChief Scientific & Med OfficerOct 06Sale35.212,50088,02579,399Oct 07 05:06 PM
Anderson Bonnie HChairman and CEOSep 10Option Exercise8.8620,000177,200240,231Sep 14 05:11 PM
Anderson Bonnie HChairman and CEOSep 10Sale30.8920,000617,861220,231Sep 14 05:11 PM
Kennedy Giulia CChief Scientific & Med OfficerSep 04Option Exercise7.666,47949,61886,426Sep 08 05:54 PM
Kennedy Giulia CChief Scientific & Med OfficerSep 04Sale31.107,027218,56479,399Sep 08 05:54 PM
Hanna John Walter JRChief Commercial OfficerAug 31Option Exercise8.4356,443475,978131,077Sep 01 05:08 PM
Hanna John Walter JRChief Commercial OfficerAug 31Sale33.3756,4431,883,55074,634Sep 01 05:08 PM
Hanna John Walter JRChief Commercial OfficerAug 21Option Exercise8.861,40012,40476,034Aug 25 05:10 PM
Hanna John Walter JRChief Commercial OfficerAug 21Sale36.001,40050,40574,634Aug 25 05:10 PM
Anderson Bonnie HChairman and CEOAug 10Option Exercise8.8620,000177,200242,207Aug 12 06:37 PM
JONES EVAN/ FADirectorAug 03Sale35.1620,000703,11769,653Aug 04 07:59 PM
Hanna John Walter JRChief Commercial OfficerJul 31Option Exercise8.8614,095124,88288,729Aug 04 08:11 PM
Kennedy Giulia CChief Scientific & Med OfficerJul 31Option Exercise20.2120,000404,200100,487Aug 04 08:05 PM
Hanna John Walter JRChief Commercial OfficerJul 31Sale36.1214,095509,14574,634Aug 04 08:11 PM
Kennedy Giulia CChief Scientific & Med OfficerJul 31Sale35.3320,000706,69480,487Aug 04 08:05 PM
JONES EVAN/ FADirectorJul 31Sale35.6720,000713,30689,653Aug 04 07:59 PM
Anderson Bonnie HChairman and CEOJul 30Option Exercise8.8611,365100,694283,572Jul 31 04:32 PM
Anderson Bonnie HChairman and CEOJul 30Sale32.2411,365366,399272,207Jul 31 04:32 PM
Anderson Bonnie HChairman and CEOJul 23Option Exercise8.863,28029,061275,487Jul 27 05:04 PM
Anderson Bonnie HChairman and CEOJul 23Sale32.043,280105,106272,207Jul 27 05:04 PM
Anderson Bonnie HChairman and CEOJul 22Option Exercise8.86100886272,307Jul 22 06:09 PM
Anderson Bonnie HChairman and CEOJul 22Sale32.001003,200272,207Jul 22 06:09 PM
Hanna John Walter JRChief Commercial OfficerJul 21Option Exercise2.406531,56775,177Jul 22 06:16 PM
Anderson Bonnie HChairman and CEOJul 21Option Exercise8.863,44730,540275,654Jul 22 06:09 PM
Anderson Bonnie HChairman and CEOJul 21Sale32.093,447110,614272,207Jul 22 06:09 PM
Hanna John Walter JRChief Commercial OfficerJul 21Sale32.3665321,13174,524Jul 22 06:16 PM
Anderson Bonnie HChairman and CEOJul 20Option Exercise8.4220,349171,287292,556Jul 22 06:09 PM
Hanna John Walter JRChief Commercial OfficerJul 20Option Exercise2.4011,29427,10685,818Jul 22 06:16 PM
Hanna John Walter JRChief Commercial OfficerJul 20Sale32.0511,294361,99374,524Jul 22 06:16 PM
Anderson Bonnie HChairman and CEOJul 20Sale32.0420,349651,911272,207Jul 22 06:09 PM
JONES EVAN/ FADirectorJul 15Sale30.1210,000301,192109,653Jul 16 05:15 PM
JONES EVAN/ FADirectorJul 14Sale28.3420,000566,847119,653Jul 16 05:15 PM
EPSTEIN ROBERT SDirectorJul 13Option Exercise5.2810,00052,80010,000Jul 14 08:26 PM
Kennedy Giulia CChief Scientific & Med OfficerJul 13Option Exercise13.0516,738218,37397,225Jul 14 08:29 PM
Kennedy Giulia CChief Scientific & Med OfficerJul 13Sale29.6616,738496,47880,487Jul 14 08:29 PM
EPSTEIN ROBERT SDirectorJul 13Sale29.7310,000297,2520Jul 14 08:26 PM
Kennedy KeithCOO / CFOJul 06Option Exercise7.6747,658365,351200,309Jul 07 05:47 PM
Kennedy KeithCOO / CFOJul 06Sale28.2180,6772,276,172119,632Jul 07 05:47 PM
Kennedy KeithCOO / CFOJul 02Option Exercise5.982,80016,744158,398Jul 07 05:47 PM
Kennedy KeithCOO / CFOJul 02Sale28.025,747161,040152,651Jul 07 05:47 PM
Anderson Bonnie HChairman and CEOJun 10Option Exercise4.0020,00080,000292,207Jun 11 07:06 PM
Anderson Bonnie HChairman and CEOJun 10Sale26.5620,000531,260272,207Jun 11 07:06 PM
Kennedy Giulia CChief Scientific & Med OfficerJun 03Option Exercise7.5410,23977,25191,273Jun 04 04:16 PM
Kennedy Giulia CChief Scientific & Med OfficerJun 03Sale26.2210,786282,80980,487Jun 04 04:16 PM
Cohen Fred EDirectorMay 18Sale26.8640,0001,074,5550May 19 04:04 PM
Anderson Bonnie HChairman and CEOMay 11Option Exercise4.0020,00080,000294,183May 13 04:47 PM
Anderson Bonnie HChairman and CEOMay 11Sale26.6720,000533,334274,183May 13 04:47 PM
Anderson Bonnie HChairman and CEOMar 20Option Exercise2.6816,00042,880272,313Mar 23 05:01 PM
Anderson Bonnie HChairman and CEOMar 10Option Exercise4.0020,00080,000276,313Mar 11 05:05 PM
Anderson Bonnie HChairman and CEOMar 10Sale25.1820,000503,520256,313Mar 11 05:05 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 03Option Exercise7.1315,033107,111114,155Mar 04 05:49 PM
Kennedy Giulia CChief Scientific & Med OfficerMar 03Sale25.3932,881834,79881,274Mar 04 05:49 PM
Kennedy KeithCOO / CFOJan 16Option Exercise7.477,05252,678116,755Jan 21 04:23 PM
JONES EVAN/ FADirectorJan 16Sale30.1114,049422,975139,653Jan 21 04:25 PM
Kennedy KeithCOO / CFOJan 16Sale30.087,052212,104109,703Jan 21 04:23 PM
JONES EVAN/ FADirectorJan 14Sale28.505,000142,521153,702Jan 15 04:54 PM
Anderson Bonnie HChairman and CEOJan 10Option Exercise4.0020,00080,000137,738Jan 13 04:23 PM
Anderson Bonnie HChairman and CEOJan 10Sale28.8620,000577,276117,738Jan 13 04:23 PM
Kennedy KeithCOO / CFODec 27Option Exercise7.474002,988110,103Dec 31 04:09 PM
Kennedy KeithCOO / CFODec 27Sale30.0040012,002109,703Dec 31 04:09 PM
JONES EVAN/ FADirectorDec 17Sale29.2615,000438,866158,702Dec 18 04:37 PM
Anderson Bonnie HChairman and CEODec 10Option Exercise3.4335,000120,200122,738Dec 11 04:46 PM
Anderson Bonnie HChairman and CEODec 10Sale28.9620,000579,248102,738Dec 11 04:46 PM
Hanna John Walter JRChief Commercial OfficerDec 06Option Exercise9.059,83889,03475,113Dec 09 04:17 PM
Kennedy KeithCOO / CFODec 06Option Exercise7.4713,851103,467123,554Dec 09 04:12 PM
Hanna John Walter JRChief Commercial OfficerDec 06Sale30.099,838295,99565,275Dec 09 04:17 PM
JONES EVAN/ FADirectorDec 06Sale30.0380024,022173,702Dec 09 04:19 PM
Kennedy KeithCOO / CFODec 06Sale30.0413,851416,146109,703Dec 09 04:12 PM
Kennedy KeithCOO / CFODec 05Option Exercise6.9019,300133,208129,003Dec 09 04:12 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 05Option Exercise14.3432,803470,39579,665Dec 09 04:15 PM
Hanna John Walter JRChief Commercial OfficerDec 05Option Exercise9.058,10073,30573,375Dec 09 04:17 PM
JONES EVAN/ FADirectorDec 05Sale30.005,151154,535174,502Dec 09 04:19 PM
Hanna John Walter JRChief Commercial OfficerDec 05Sale30.018,100243,04765,275Dec 09 04:17 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 05Sale29.3932,803964,14246,862Dec 09 04:15 PM
Kennedy KeithCOO / CFODec 05Sale30.0019,300579,069109,703Dec 09 04:12 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 03Option Exercise7.1215,032107,10362,189Dec 04 04:22 PM
Kennedy Giulia CChief Scientific & Med OfficerDec 03Sale26.4715,327405,66346,862Dec 04 04:22 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 27Option Exercise14.343,69753,01551,146Dec 02 04:13 PM
Kennedy Giulia CChief Scientific & Med OfficerNov 27Sale29.363,697108,53447,449Dec 02 04:13 PM
Hanna John Walter JRChief Commercial OfficerNov 26Option Exercise8.9915,497139,34680,989Nov 27 04:30 PM
Hanna John Walter JRChief Commercial OfficerNov 26Sale28.5515,497442,48065,492Nov 27 04:30 PM
Kennedy KeithCOO / CFONov 25Option Exercise5.9818,757112,167128,800Nov 27 04:28 PM
Hanna John Walter JRChief Commercial OfficerNov 25Option Exercise8.982,44121,91567,933Nov 27 04:30 PM
Hanna John Walter JRChief Commercial OfficerNov 25Sale28.522,44169,61065,492Nov 27 04:30 PM
Kennedy KeithCOO / CFONov 25Sale28.0118,757525,475110,043Nov 27 04:28 PM
Hanna John Walter JRChief Commercial OfficerNov 18Option Exercise6.4519,571126,23385,063Nov 19 05:38 PM
Hanna John Walter JRChief Commercial OfficerNov 18Sale25.1819,571492,78865,492Nov 19 05:38 PM
Anderson Bonnie HChairman and CEONov 15Option Exercise4.0020,00080,000123,726Nov 18 04:19 PM
Anderson Bonnie HChairman and CEONov 15Sale25.0620,000501,124103,726Nov 18 04:19 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.